The clinical significance of cereblon expression in multiple myeloma-Reference-Cited by-同舟云学术

The clinical significance of cereblon expression in multiple myeloma

Published:2014-01 Issue:1 Volume:38 Page:23-28
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Schuster Steven R.,Kortuem K. Martin,Zhu Yuan Xiao,Braggio Esteban,Shi Chang-Xin,Bruins Laura A.,Schmidt Jessica E.,Ahmann Greg,Kumar Shaji,Rajkumar S. Vincent,Mikhael Joseph,LaPlant Betsy,Champion Mia D.,Laumann Kristina,Barlogie Bart,Fonseca Rafael,Bergsagel P. Leif,Lacy Martha,Stewart A. Keith

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference24 articles.

1. Treatment of multiple myeloma;Rajkumar;Nat Rev Clin Oncol,2011

2. Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity;Parman;Nat Med,1999

3. Thalidomide is an inhibitor of angiogenesis;D’Amato;Proc Natl Acad Sci USA,1994

4. Identification of a primary target of thalidomide teratogenicity;Ito;Science,2010

5. Pomalidomide and lenalidomide induce p21 WAF-1 expression in both lymphoma and multiple myeloma through a LSD1-mediated epigenetic mechanism;Escoubet-Lozach;Cancer Res,2009

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitors and PROTACs of CDK2: challenges and opportunities;Expert Opinion on Drug Discovery;2024-07-12

2. Targeting the ubiquitin pathway in lymphoid malignancies;Cancer Letters;2024-07

3. The emerging role of targeted protein degradation to treat and study cancer;The Journal of Pathology;2024-06-17

4. MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance;Clinical Cancer Research;2024-05-09

5. Evaluation of cereblon expression in gastrointestinal tract tumors;2024-04-19